Drug Topics

DECEMBER 12, 2024

Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients exacerbations.

186

186

STAT

DECEMBER 12, 2024

Testing of samples taken from a child in California thought to have contracted H5N1 bird flu after drinking raw milk turned up no evidence of influenza viruses, the Centers for Disease Control and Prevention said Thursday.  A test run on a sample from the child — who went to a Marin County emergency department last week with a fever and vomiting — had been positive there for flu A.

144

144

Pharmacy Times

DECEMBER 9, 2024

Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.

149

149

IDStewardship

DECEMBER 13, 2024

In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. Antimicrobial stewardship metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the safe and appropriateuse of antibiotics.

Communication 130

Communication Medical Records Documentation 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

DECEMBER 13, 2024

US Senators introduced the bipartisan bill addressing pharmacy benefit managers and their affiliated pharmacies.

181

181

STAT

DECEMBER 12, 2024

Like many Americans, Holden Karau said she was fed up with health insurance. The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. She said the hassles piled on stress, forced her to pay more out of pocket, and delayed access to care she needed to recover from multiple broken bones.

Insurance 143

Insurance 143

Pharmaceutical Technology

DECEMBER 9, 2024

Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.

120

120

Drug Topics

DECEMBER 8, 2024

Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.

187

187

STAT

DECEMBER 11, 2024

Gilead said Tuesday that it will soon begin Phase 3 testing for a drug it believes could prevent HIV infection with just a single shot every year. Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research. The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027.

Vaccines 145

Vaccines 145

Pharmacy Times

DECEMBER 11, 2024

The combination vaccine candidates will be evaluated in 2 separate phase 1/2 clinical trials.

Vaccines 138

Vaccines FDA 138

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

DECEMBER 12, 2024

In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US publics health in jeopardy.

102

102

Drug Topics

DECEMBER 13, 2024

See whats trending in pharmacy with a preview of the Total Pharmacy December issue.

98

98

STAT

DECEMBER 10, 2024

The Ohio Supreme Court ruled that three of the largest pharmacy chain operators in the U.S. could not be held liable under a state nuisance law for contributing to the long-running opioid crisis. In a 5-to-2 vote, the court determined that the law barred two Ohio counties from obtaining a $650.9 million judgement that was won in a federal court against CVS Health, Walgreens, and Walmart.

143

143

Pharmacy Times

DECEMBER 8, 2024

The phase 3 AMPLIFY trial demonstrates that fixed-duration regimens of acalabrutinib and venetoclax, with or without obinutuzumab, significantly improve progression-free survival and deliver manageable safety profiles compared to chemoimmunotherapy in treatment-naive chronic lymphocytic leukemia (CLL).

142

142

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

The Checkup by Singlecare

DECEMBER 10, 2024

Trulicity (dulaglutide) and Ozempic (semaglutide) are both brand-name medications approved by the Food and Drug Administration (FDA) to help treat Type 2 diabetes. Because these drugs suppress appetite, some healthcare providers prescribe them off-label for weight loss. However, another medication with the same active ingredient as Ozempic has been FDA approved for weight loss and is sold under the brand name Wegovy.

Dosage 98

Dosage Insurance Coverage Labelling Insurance 98

Drug Topics

DECEMBER 13, 2024

A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.

Hospitals 98

Hospitals 98

STAT

DECEMBER 12, 2024

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma.  There’s more to life than protein folding.

130

130

Pharmacy Times

DECEMBER 9, 2024

Pharmacists play a key role in vaccination efforts to prevent respiratory illnesses.

Vaccines 139

Vaccines 139

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

DECEMBER 12, 2024

Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.

Vaccines 99

Vaccines FDA 99

Drug Topics

DECEMBER 13, 2024

Denise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.

Adverse Reactions 98

Adverse Reactions 98

STAT

DECEMBER 10, 2024

Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug abuse, making it the first major drugmaker to do so, CEO David Ricks said Tuesday. Emerging research suggests that GLP-1 drugs — Zepbound is one such treatment — not only reduce food cravings but may also suppress desires for other substances.

145

145

Pharmacy Times

DECEMBER 9, 2024

Luca Bertamini, MD highlights the potential clinical implications of using circulating tumor cells as a biomarker in patients with newly-diagnosed multiple myeloma.

139

139

Pharmaceutical Technology

DECEMBER 9, 2024

Citryll has secured an oversubscribed Series B funding round, raising 85m ($89.8m) to advance the clinical development of CIT-013.

104

104

Drug Topics

DECEMBER 13, 2024

A conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.

98

98

STAT

DECEMBER 11, 2024

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on Wednesday, but some Wall Street analysts believe the legislation is unlikely to gain much traction, at least for now. The bipartisan bill , which would require divestiture within three years, is aimed at what the lawmakers call an “inherent conflict of interest” that has forced Americans to pay more for medicines and hastened the

Insurance 136

Insurance Independent Pharmacies 136

Pharmacy Times

DECEMBER 9, 2024

The phase 3 CEPHEUS trial demonstrated that adding daratumumab (DARA) to the VRd regimen significantly improves minimal residual disease negativity, progression-free survival, and overall response in transplant-ineligible or transplant deferred patients with newly diagnosed multiple myeloma, establishing a new standard of care.

139

139

Compounding Pharmacy of America

DECEMBER 12, 2024

Discover the symptoms, causes, and natural treatments for adrenal fatigue. Learn how tools like the Adrenal Stress Test Kit and targeted supplements can restore balance and energy. The post Understanding Adrenal Fatigue appeared first on Compounding Pharmacy of America.

Compounding Pharmacies 97

Compounding Pharmacies Compounding 97

Drug Topics

DECEMBER 13, 2024

Kathryn Litten, PharmD, discussed the pharmacists role in helping patients manage metabolic dysfunction-associated steatotic liver disease.

98

98

STAT

DECEMBER 8, 2024

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a panel discussion among sickle cell experts Saturday at STAT@ASH , which took place during the American Society of Hematology’s annual meeting. They said patients were despondent over how suddenly the drug was pulled from the market in September because there had been no clear indication of problems in advance of the announcement.

129

129

Pharmacy Times

DECEMBER 8, 2024

In hospital and critical care settings, pharmacists can play a significant role in educating other health care providers about treatment options, proper dosing, and more.

Hospitals 139

Hospitals 139

The Honest Apothecary

DECEMBER 13, 2024

Monday evening I was frustrated. Four weeks ago we had begun trying the carnivore diet. For me, it was an attempt to try something different to hopefully break out of a 6-month stall in my weight loss journey. Yes, that’s right. I began exercising and eating much better 1 year ago. Over the course of […] The post My 72-Hour Fast appeared first on The Honest Apothecary.

94

94

Drug Topics

DECEMBER 12, 2024

Researchers presented the community-wide benefits of a collaborative pharmacy-driven vaccine clinic in an urban setting.

Vaccines 98

Vaccines 98

STAT

DECEMBER 10, 2024

Cockroaches are a hardy pest, and often elicit disgust. But they do have a few things going for them: They are cheap, can be raised in a space as small as a shoebox, and aren’t dangerous to humans. That makes the insects uniquely qualified for neuroscience outreach, according to researchers trying to create low-cost tools and free computer programs that can entice students in high school and college to pursue careers in the field.

129

129